9 recruiting, 2 active not recruiting, 2 not yet recruiting, 1 completed. 8 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 8 | Recruiting 4, Not yet recruiting 2, Active not recruiting 1, Completed 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Sentinel Lymph Node Biopsy (SLNB): new trials by email Literature Review of Sentinel Lymph Node Biopsy (SLNB) trials Research Report on Sentinel Lymph Node Biopsy (SLNB)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SENTInel Node Mapping Versus Comprehensive Lymphadenectomy in p53-Mutated Endometrial Cancer: A Non-Inferiority Randomized Trial Sentinel Lymph Node Mapping, Comprehensive pelvic and para-aortic lymphadenectomy - Lymphadenectomy, Endometrial Cancer | Not applicable | Not yet recruiting | University Hospital, Strasbourg, France | 374 | 2026-06-01 | 2026-02-17 |
| Evaluating a Decision Aid for Sentinel Lymph Node Biopsy in Intermediate-Risk Melanoma Decision Aid - Sentinel Lymph Node Biopsy (SLNB), Melanoma (Skin Cancer) | Not applicable | Not yet recruiting | University of Virginia | 66 | 2026-06-01 | 2026-06-17 |
| Patent Blue SLN in Early Ovarian Cancer Prospective Study (FIGO I-II) Evaluating Patent Blue SLN Mapping. Injection Into IP/UO Ligaments in Situ. Goals: Assess Feasibility and Accuracy vs Standard Lymphadenectomy to Minimize Surgical Morbidity Sentinel node biopsy with patent blue dye - Sentinel Lymph Node Biopsy (SLNB), Early Stage Ovarian Tumors | Recruiting | Faculty of Medicine of Tunis | 30 | 2026-04-15 | 2026-09-10 | |
| Upfront Targeted Axillary Dissection for Luminal Breast Cancer With Limited Axillary Involvement Upfront Targeted Axillary Dissection (UTAD) - ALND, Sentinel Lymph Node Biopsy (SLNB) | Recruiting | European Institute of Oncology | 150 | 2026-01-28 | 2026-06-16 | |
| Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in IBC SLN identification using technetium-99m, SLN intra-operatory identification with radioguided surgery, Axillary Limph Node Dissection (ALND) - Invasive Breast Carcinoma, Sentinel Lymph Node Biopsy (SLNB) | Not applicable | Recruiting | European Institute of Oncology | 75 | 2025-12-12 | 2026-01-06 |
| Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer Technetium (99mTc), Indocyanine Green, Sentinel lymph node biopsy - Breast Cancer, Sentinel Lymph Node Biopsy (SLNB) | Not applicable | Recruiting | Isabelle Henskens | 1760 | 2025-04-18 | 2026-06-25 |
| Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative Sentinel Node Biopsy, Limited Elective Neck Dissection - Mouth Neoplasms, Oral Cancers | Not applicable | Recruiting | Tata Memorial Hospital | 508 | 2025-04-16 | 2025-07-17 |
| Rapid Assessment of Sentinel Lymph Node Metastasis Status Using a Pan-CK-targeting NIR-II Fluorescent Probe in Breast Cancer NIR-II probe (i.e ICG-CK) incubation solution - Breast Cancer Metastatic, Sentinel Lymph Node | Recruiting | Yunnan Cancer Hospital | 60 | 2025-02-01 | 2025-09-04 | |
| Audit of Targeted Sentinel Node Biopsy (TSNB) in Patients With Limited Nodal Disease Undergoing Primary Surgery Targeted Sentinel Node Biopsy (TSNB) - Breast Cancer, Axillary Lymph Nodes Dissection | Recruiting | University Hospitals of Derby and Burton NHS Foundation Trust | 400 | 2025-01-17 | 2026-10-22 | |
| Application of Targeted Axillary Lymph Node Resection in Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: an Open-label, Multicenter Study carbon suspension - Breast Cancer Surgery, Neoadjuvant Therapy | Not applicable | Active not recruiting | Fujian Medical University Union Hospital | 175 | 2024-12-09 | 2025-06-22 |
| Photo-medicine-Guided Dual Approach for Reoperation of Sentinel Lymph Nodes in Locally Recurrent Breast Cancer Patients Identification rate of sentinel lymph node - Breast Cancer, Locally Recurrent Breast Cancer | Phase 2 | Recruiting | National Cancer Center, Korea | 30 | 2023-08-13 | 2025-01-17 |
| Finding Sentinel Lymph Nodes During Mastectomy Using Indocyanine Green (INIGMA Study) Indocyanine green (ICG)-fluorescence guided sentinel lymph node biopsy - Breast Cancer, Sentinel Lymph Node Biopsy (SLNB) | Not applicable | Recruiting | Isabelle Henskens | 90 | 2022-08-22 | 2026-01-23 |
| Real-time Lymphatic Channel Visualization Improves Bilateral Sentinel Lymph Node Detection in Endometrial Cancer indocyanine green - Endometrial Cancer, Endometrial Neoplasms | Not applicable | Completed | Bakirkoy Dr. Sadi Konuk Research and Training Hospital | 80 | 2021-07-13 | 2025-09-24 |
| Sentinel Lymph Node Detection in Gastric Cancer Using a Dual Tracer (Superparamagnetic Iron Oxide and Methylene Blue): A Prospective Study With Histological and OSNA Validation Dual tracer: The infiltration of the Supermagnetic Iron Oxide (SPIO) and Methylene Blue, OSNA AND H-E - Gastric Cancer (GC), Sentinel Lymph Node Biopsy (SLNB) | Active not recruiting | Hospital del SAS de Jerez | 44 | 2017-08-01 | 2025-08-29 |
Breast Neoplasms (5) · Endometrial Neoplasms (2) · Lymphatic Metastasis (2) · Melanoma (1) · Mouth Neoplasms (1) · Neoplasm Metastasis (1) · Squamous Cell Carcinoma of Head and Neck (1) · Stomach Neoplasms (1) · Uterine Neoplasms (1)
Neoplasms (10) · Neoplasms by Site (10) · Skin Diseases (6) · Skin and Connective Tissue Diseases (6) · Breast Diseases (5) · Neoplastic Processes (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases (2) · Genital Diseases, Female (2) · Genital Neoplasms, Female (2) · Neoplasm Metastasis (2) · Neoplasms by Histologic Type (2)
Indocyanine Green (3) · Sentinel Lymph Node Biopsy (3) · Decision Support Techniques (1) · Methylene Blue (1) · Optical Imaging (1) · Technetium (1) · Technetium-99 (1) · ferric oxide (1)
European Institute of Oncology (2) · Isabelle Henskens (2) · Bakirkoy Dr. Sadi Konuk Research and Training Hospital (1) · Faculty of Medicine of Tunis (1) · Fujian Medical University Union Hospital (1) · Hospital del SAS de Jerez (1) · National Cancer Center, Korea (1) · Tata Memorial Hospital (1) · University Hospital, Strasbourg, France (1) · University Hospitals of Derby and Burton NHS Foundation Trust (1) · University of Virginia (1) · Yunnan Cancer Hospital (1)
China (2) · Italy (2) · Netherlands (2) · India (1) · South Korea (1) · Spain (1) · Switzerland (1) · Tunisia (1) · Turkey (Türkiye) (1) · United Kingdom (1) · United States (1)
Amit Goyal (1) · Annemiek Doeksen, MD, PhD (1) · Chuan Wang (1) · Richa Vaish, MS, M.Ch (1) · Russell Witt, MD (1)
PMID 25004343, PMID 31912902, PMID 33906784, PMID 41796475, PMID 42342397